These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7141263)

  • 1. [Results of treatment of advanced cases of endometrial cancer with high doses of medroxyprogesterone].
    Wittczak-Ploch E
    Ginekol Pol; 1982; 53(3):123-8. PubMed ID: 7141263
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surface changes in endometrial cancer under the effect of large doses of progestogen (Depo-Provera)].
    Szarvas Z; Zsolnai B
    Morphol Igazsagugyi Orv Sz; 1984 Apr; 24(2):92-9. PubMed ID: 6717452
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormonoprophylaxis and hormonotherapy in the treatment of endometrial adenocarcinoma by means of medroxyprogesterone acetate.
    Bonte J; Decoster JM; Ide P; Billiet G
    Gynecol Oncol; 1978 Feb; 6(1):60-75. PubMed ID: 620950
    [No Abstract]   [Full Text] [Related]  

  • 4. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
    Thurzó L
    Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S; Patton R
    Minerva Ginecol; 1981 Apr; 33(4):293-306. PubMed ID: 7243070
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of advanced endometrial adenocarcinoma with cyclic sequential ethinyl estradiol and medroxyprogesterone acetate.
    Tatman JL; Freedman RS; Scott W; Atkinson EN
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1619-21. PubMed ID: 2531671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medroxyprogesterone acetate release from silastic devices as replacement for local irradiation by radium tubes in preoperative intrauterine packing for endometrial adenocarcinoma: a preliminary study.
    Decoster JM; Bonte J; Marcq A
    Gynecol Oncol; 1977 Jun; 5(2):189-95. PubMed ID: 881131
    [No Abstract]   [Full Text] [Related]  

  • 8. [Synthetic progestational hormones in high doses in adenocarcinoma of the endometrium. (Study of carbohydrate metabolism)].
    Pasquinucci C
    Minerva Ginecol; 1970 Oct; 22(19):950-6. PubMed ID: 5516459
    [No Abstract]   [Full Text] [Related]  

  • 9. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK; Titova VA
    Sov Med; 1990; (9):102-7. PubMed ID: 2148437
    [No Abstract]   [Full Text] [Related]  

  • 10. [MAP in the treatment of adenocarcinoma of the endometrium].
    Leone F; De Placido G; Frollo G
    Minerva Ginecol; 1979 Apr; 31(4):251-5. PubMed ID: 460664
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)].
    Ohta M; Takeda A; Ninagawa T; Tomoda Y
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1098-103. PubMed ID: 6453176
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
    Cohen CJ; Deppe G; Bruckner HW
    Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
    Kline RC; Freedman RS; Jones LA; Atkinson EN
    Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medroxyprogesterone and endometrial adenocarcinoma].
    Serment H; Spitalier JM; Ayme Y; Degiovanni E; Bardin JP
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):93-7. PubMed ID: 5453572
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
    Bruckner HW; Deppe G
    Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adenocarcinoma of the endometrium while undergoing contraceptive treatment with medroxyprogesterone].
    Stamm H; De Grandi P
    Rev Med Suisse Romande; 1981 Nov; 101(11):913-7. PubMed ID: 7323568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormonal and surgical treatment of endometrial adenocarcinoma. Long-term follow-up. Results].
    D'Incerti Bonini L
    Minerva Ginecol; 1976; 28(7-8):630-8. PubMed ID: 1018851
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral high doses of medroxyprogesterone acetate (MPA) in the treatment of advanced phases of breast and endometrial cancer].
    Bernardo-Strada MR; Imparato E; Aspesi G; Pavesi L; Robustelli Della Cuna G
    Minerva Med; 1980 Nov; 71(44):3241-6. PubMed ID: 7454090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local use of progestogen in cancer.
    Craft IL
    Br Med J; 1969 Jul; 3(5662):115. PubMed ID: 5790259
    [No Abstract]   [Full Text] [Related]  

  • 20. [Successful treatment of advanced endometrial carcinoma with pleural effusion due to cancer by cisplatin, doxorubicin, and medroxyprogesterone acetate].
    Hayashi Y; Hachisuga M; Tateyama H
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1173-6. PubMed ID: 3611885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.